Citation: Pj. Mutch et al., Formation of a defluorinated metabolite of a quinoxaline antiviral drug catalysed by human cytochrome P450 1A2, J PHARM PHA, 53(3), 2001, pp. 403-408
Authors:
Dear, GJ
Ismail, IM
Mutch, PJ
Plumb, RS
Davies, LH
Sweatman, BC
Citation: Gj. Dear et al., Urinary metabolites of a novel quinoxaline non-nucleoside reverse transcriptase inhibitor in rabbit, mouse and human: identification of fluorine NIH shift metabolites using NMR and tandem MS, XENOBIOTICA, 30(4), 2000, pp. 407-426
Authors:
Ismail, IM
Dear, GJ
Mutch, PJ
Davies, LH
Plumb, RS
Sweatman, BC
Citation: Im. Ismail et al., Urinary metabolites of a novel quinoxaline nonnucleoside reverse transcriptase inhibitor in dog, cynomolgus monkey and mini-pig, XENOBIOTICA, 29(9), 1999, pp. 957-967
Authors:
Dear, GJ
Ayrton, J
Plumb, R
Sweatman, BC
Ismail, IM
Fraser, IJ
Mutch, PJ
Citation: Gj. Dear et al., A rapid and efficient approach to metabolite identification using nuclear magnetic resonance spectroscopy, liquid chromatography mass spectrometry and liquid chromatography nuclear magnetic resonance spectroscopy sequential mass spectrometry, RAP C MASS, 12(24), 1998, pp. 2023-2030